GYRE
GYRE THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$6.30
+3.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 3.56x
- P/S forward
- 22.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.12x
- Price / sales
- 5.59x
- Price / cash flow
- -46.04x
Enterprise value
- Enterprise value
- $653.1M
- EV / sales
- 5.47x
- EV / EBITDA
- -51.80x
- EV / EBIT
- -39.17x
- Market cap
- $667.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026